2 years ago

57- NE Grañana - Agosto 2009

  • Text
  • Atomoxetina
  • Risperidona
  • Metilfenidato
  • Autista
  • Hiperactividad
  • Trastornos
  • Autistas
  • Autistic
  • Autism
  • Atencional
  • Desarrollo
  • Sostenida
  • Respuesta
  • Visual
Alteraciones de la atención en trastornos del espectro autista

Dra. Nora E.

Dra. Nora E. Grañana Referencias bibliográficas - Burack J, Enns J, Stauder J, Mottron L, Randolph B. Attention and autism: behavioral and electrophysiological evidence. En: Cohen K, Volkmar F Eds. Handbook of autism and pervasive developmental disorders. J Wiley Ed. NY 2005; 226-247. - Aman M y Langworthy K. Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders. J Autism Dev Disord. 2000; 30(5):451-460. - DSM IV TR. American Psychiatric Association (2002). Diagnostic and statistical manual of mental disorders (4th ed.) Revised Text. Washington DC: Author. - Plude D, Enns J, Brodeur D. The development of selective attention: a life span overview. Acta Psychologica 1994; 86:227-272. - Frith U. ¿Qué es el autismo? En: Autismo. Alianza ED. 1997:23-41. - Rapin I. Autism. N Engl J Med 1997; 337 (2) 97-104. - Rapin I. Autismo: un síndrome de disfunción neurológica. En: Fejerman N. Fernández Álvarez E (Eds) Neurología Pediátrica. 3 Edición. Panamericana Bs. As. 2007:693-705. - Hochman J. La bataille de l’autisme. En: Hochman J. Pour soigner l’enfant austiste. Edit Odile Jacob. Paris. 1997. 15-57. - Tantam D. Asperger syndrome in adulthood. In: Frith U. Austism and Asperger syndrome. Cambridge. Cambridge. UK. 1997: 147-183. - Courchesne E, Towsend, Akshoomoff N, Saitoh O, Yeung-Courchesne R, Lincoln A et al. Impairment in shifting attention in autistic and cerebellar patients. Behavioral Neuroscience 1994; 108:845-865. - Robbins T. Integración de las dimensiones neurobiológica y neuropsicológica del autismo. En Russell J: El autismo como trastorno de la función ejecutiva. Panamericana. Buenos Aires. 2000: 23-54. - AAP. American Academy of Pediatrics. The pediatrician role in the diagnosis and management of autistic spectrum disorder in children. Committee on Children with disabilities 2000- 2001. Pediatrics 2001; 107(5):297-315. - Mirsky A. Behavioral and psychophysiological markers of disordered attention. Environ Hlth Perspect. 1987; 74:191-199. - Posner M, Digirolamo G. Attention in cognitive neuroscience: an overview. En: Gazzaniga Ed. The new cognitive neurosciences. 2 Ed. The MIT Press- Cambridge Mass. EUA. 2000; 623- 631. - Goldstein G, Johnson C, Minshew N. Attentional processes in autism. J Autism Dev Disord 2001; 31(4):433-440. - Barry R, James A. Coding of stimulus parameters in autistic, retarded, and normal children: evidence for a two factor theory of autism. International Journal of Psychophysiology 1988; 6:139-149. - Garretson H, Fein D, Waterhoruse L. Sustainted attention in children with autism. J Aut Developmental Dis 1990; 20: 101-104. - Notterdaeme M, Amorosa H, Mildenberger K, Sitter K, Minow F. Evaluation of attention problems in children with autism and children with a specific language disorder. European Child & Adolesc Psychiatry 2001; 10: 58-66. - Casey B, Gordon C, Manheim B, Rumsey J. Dysfunctional attention in autistic savants. J Clin and Experimental Neuropsychology 1993; 15:933-946. - Swaab-Barneveld H, Sonneville L, Cohen- Kettenis P, Gielen A, Buitelaar J, Van Engeland H. Visual sustained attention in a child psychiatric population. J Am Acad Child Adolesc Psychiatry 2000; 39(5):651-659. - Ozonoff S. Componentes de la función ejecutiva en el autismo y otros trastornos. En: Russell J. El autismo como trastorno de la función ejecutiva. Panamericana. Buenos Aires. 2000; 177- 204. - Ozonoff S, Strayer D. Further evidence of intact working memory. J Autism Dev Disord 2001; 31 (3):257-264. - Mundy P, Sigman M, Kasari C. A longitudinal study of joint attention and language development in autistic children. J Autism Dev Disord 1990; 22:115-127. - Rollins P, Wambacq I, Dowell D, Mathews L, Reese P. An intervention technique for children with autistic spectrum disorder: joint attentional routines. J Commun Disord 1998; 31:181- 193. - Kylliainen A, Hietanen J. Attention orienting by another´s gaze direction in children with autism. J Child Psychol Psychiatry 2004; 45 (3):435-44. - Towsend J, Westerfield M, Leaver E, Makeig S, Jung T, Pierce K, Courchesne E. Event-related response abnormailities inautism: evidence for impaired cerebello-frontal spatial attention networks. Cognitive Brain Res 2001; 11:127-145. - Harris S, Courchesne E, Towsend J, Carper R, Lord C. Neuroanatomic contributions to slowed orienting of attention in children with autism. Cognitive Brain Res 1999; 8:61-71. - Perry R, Pataki C, Muñoz-Silva et al. Risperidone in children and adolescents with pervasive developmental disorders: pilot trial and follow-up. J Ch Adolesc Psychopharmacology 1997; 7:167-179. - Nicolson R, Awad G, Sloman L. An open trial of risperidone in young autistic children. Am Acad Ch Adolesc Psychiatry 1998; 37:372- 376. - Aman M, Farmer C, Hollway J, Arnold L. Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders. Child Adolesc Psychiatr Clin N Am. 2008; 17(4):713-38. - Realmuto G, August G, Garfinkel B. Clinical effect of buspirone in autistic children. J Clin Psychopharmacol 1989; 9:122-125. - Wing L. Wing schedule of handicaps, behaviour and skills (HBS). In: Rapin I Edit. Preschool children with inadequate communication. Clin in Developmental Medicine N 139. Cambridge Press. NY. 1996; 268-296. - Lord C, Risi S, Lambretch L et al. The Autism Diagnostic Observation Schedule-Generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 2000; 30 (3):205-224. - Yoshida V, Uchiyama T. The clinical necessitty for assessing attention deficit/hyperactivity disorder (AD/HD) symptoms in children with high-function Pervasive Developmental Disorder (PDD). Eur Child Adolesc Psychiatry 2004; 13 (5):307-14. - Jou R., Handen B, Hardan A. Retrospective Assessment of Atomoxetine in Children and Adolescents with Pervasive Developmental Disorders. Journal Of Child And Adolescent Psychopharmacology 2005; 15 (2):325–330. - Di Martino A, Melis G, Cianchetti C, Zuddas A. Methylphenidate for pervasive developmental disorders: safe and efficacy of acute single dose test and ongoing therapy: an open study. J Child Adolesc Psychopharmacol 2004; 14(2):207- 218. - Handen B, Johnson C, Lubetsky M. Efficacy of metilphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder. J Autism Dev Disord 2000; 30(3): 245- 256. - Frankhauser M, Karumanchi V, German M, et al. A double-blind placebo-controlled study of the efficacy of transdermal clonidine in autism. J Clin Psychiatry 1991; 53:77-82. - Moussavand S y Findling L. Recent Advances in the Pharmacological Treatment of Pervasive Developmental Disorders. Current Pediatric Reviews, 2007; 3, 79-91. - Lovaas I, Koegel R, Schreibman L. Stimulus overselectivity in autism: a review of research. Psychol Bulletin 1979; 86:1236- 1254. - Gordon C, Rapoport J, Hamburger S et al. Differential response of seven subjects with autistic disorder to clomipramine and desipramine. Am J Psychiatry 1992; 149:363- 366. - Fatemi S, Realmuto G, Khan L, Thuras P. Fluoxetine in treatment of adolescent patients with autism: a longitudinal open trial. J Autism Dev Disord 1998; 28:303-307. - Geurts H, Verte S, Oosterlaan J, Roeyers H, Sergeant J. How specific are executive functioning deficits in attention deficit hyperactivity disorder and autism? J Child Psychol Psychiatry 2004; 45 (4):836-54. 32 // EDITORIAL SCIENS